LASA SUPERGENERICS Financial Statement Analysis
|
||
The Revenues of LASA SUPERGENERICS have decreased by -32.24% YoY .
The Earnings Per Share (EPS) of LASA SUPERGENERICS has decreased by Negative YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
LASA SUPERGENERICS Last 5 Annual Financial Results
[BOM: 540702|NSE : LASA]
Standalone | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹137 Cr | ₹202 Cr | ₹167 Cr | ₹170 Cr | ₹244 Cr |
Expenses | ₹121 Cr | ₹155 Cr | ₹137 Cr | ₹159 Cr | ₹202 Cr |
Operating Profit (Excl OI) | ₹16 Cr | ₹47 Cr | ₹30 Cr | ₹11 Cr | ₹41 Cr |
Other Income | ₹0.28 Cr | ₹0.18 Cr | ₹0.23 Cr | ₹0.54 Cr | ₹3.49 Cr |
Interest | ₹0.07 Cr | ₹2.07 Cr | ₹8.12 Cr | ₹8.38 Cr | ₹11 Cr |
Depreciation | ₹15 Cr | ₹16 Cr | ₹17 Cr | ₹19 Cr | ₹18 Cr |
Profit Before Tax | ₹-6.14 Cr | ₹29 Cr | ₹4.74 Cr | ₹-16 Cr | ₹15 Cr |
Profit After Tax | ₹-5.33 Cr | ₹23 Cr | ₹3.63 Cr | ₹-12 Cr | ₹12 Cr |
Consolidated Net Profit | ₹-5.33 Cr | ₹23 Cr | ₹3.63 Cr | ₹-12 Cr | ₹12 Cr |
Earnings Per Share (Rs) | ₹-7.71 | ₹-1.06 | ₹5.60 | ₹0.89 | ₹-5.26 |
PAT Margin (%) | -29.81 | -3.89 | 11.25 | 2.17 | -7.09 |
ROE(%) | -27.97 | -3.37 | 15.17 | 2.94 | -10.81 |
ROCE(%) | -23.94 | -3.41 | 17.14 | 6.77 | -3.73 |
Total Debt/Equity(x) | 0.18 | 0.13 | 0.12 | 0.34 | 0.80 |
Key Financials |
||
Market Cap | : | ₹ 127.9 Cr |
Revenue (TTM) | : | ₹ 116.8 Cr |
Net Profit(TTM) | : | ₹ -21.4 Cr |
EPS (TTM) | : | ₹ -4.3 |
P/E (TTM) | : | - |
Industry Peers & Returns | 1W | 1M | 1Y |
LASA SUPERGENERICS | 4% | 11% | 2.4% |
SUN PHARMACEUTICAL INDUSTRIES | -0.1% | -2.8% | 50.3% |
CIPLA | 4.5% | -3.1% | 52.8% |
DR REDDYS LABORATORIES | 4.6% | 1.4% | 22.2% |
ZYDUS LIFESCIENCES | 3.1% | -4.1% | 80.4% |
DIVIS LABORATORIES | 4.7% | 10.8% | 18.1% |
MANKIND PHARMA | 2.7% | 12.4% | NA |
TORRENT PHARMACEUTICALS | 6.1% | 5.3% | 66.2% |
LUPIN | 3.1% | -1.1% | 127.4% |
LASA SUPERGENERICS Revenues
[BOM: 540702|NSE : LASA]
Y-o-Y | -32.24 % |
5 Yr CAGR | -13.37 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹137 Cr | -32.24 | |
Mar2022 | ₹202 Cr | 21.00 | |
Mar2021 | ₹167 Cr | -1.37 | |
Mar2020 | ₹170 Cr | -30.37 | |
Mar2019 | ₹244 Cr | - |
LASA SUPERGENERICS Operating Profit
[BOM: 540702|NSE : LASA]
Y-o-Y | -66.07 % |
5 Yr CAGR | -21.07 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹16 Cr | -66.07 | |
Mar2022 | ₹47 Cr | 57.53 | |
Mar2021 | ₹30 Cr | 171.16 | |
Mar2020 | ₹11 Cr | -73.22 | |
Mar2019 | ₹41 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | -49.91 % |
5 Yr CAGR | -8.88 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 11.68% | -49.91 | |
Mar2022 | 23.32% | 30.13 | |
Mar2021 | 17.92% | 174.85 | |
Mar2020 | 6.52% | -61.51 | |
Mar2019 | 16.94% | - |
LASA SUPERGENERICS Profit After Tax
[BOM: 540702|NSE : LASA]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹-5.33 Cr | Negative | |
Mar2022 | ₹23 Cr | 527.84 | |
Mar2021 | ₹3.63 Cr | Positive | |
Mar2020 | ₹-12 Cr | Negative | |
Mar2019 | ₹12 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | -29.81 % | Negative | |
Mar2022 | -3.89 % | Negative | |
Mar2021 | 11.25 % | 418.43 | |
Mar2020 | 2.17 % | Positive | |
Mar2019 | -7.09 % | - |
LASA SUPERGENERICS Earnings Per Share (EPS)
[BOM: 540702|NSE : LASA]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹-7.71 | Negative | |
Mar2022 | ₹-1.06 | Negative | |
Mar2021 | ₹5.60 | 529.21 | |
Mar2020 | ₹0.89 | Positive | |
Mar2019 | ₹-5.26 | - |
LASA SUPERGENERICS Return on Capital Employed (ROCE)
[BOM: 540702|NSE : LASA]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | -23.94% | Negative | |
Mar2022 | -3.41% | Negative | |
Mar2021 | 17.14% | 153.18 | |
Mar2020 | 6.77% | Positive | |
Mar2019 | -3.73% | - |
LASA SUPERGENERICS Share Price vs Sensex
Current Share Price | : | ₹25.5 |
Current MarketCap | : | ₹ 127.9 Cr |
Updated EOD on | : | Apr 25,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LASA SUPERGENERICS | 4% |
11% |
2.4% |
SENSEX | 1.3% |
2.6% |
24% |
LASA SUPERGENERICS related INDICES
You may also like the below Video Courses
FAQ about LASA SUPERGENERICS Financials
How the annual revenues of LASA SUPERGENERICS have changed ?
The Revenues of LASA SUPERGENERICS have decreased by -32.24% YoY .
How the Earnings per Share (EPS) of LASA SUPERGENERICS have changed?
The Earnings Per Share (EPS) of LASA SUPERGENERICS has decreased by Negative YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs